Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × pegfilgrastim × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Lymphoma 31 Neutropenia 28 Lymphoma, Large B-Cell, Diffuse 22 Lymphoma, Non-Hodgkin 17 Neoplasms 14 Hodgkin Disease 13 Sarcoma 10 Multiple Myeloma 10 Carcinoma, Non-Small-Cell Lung 10 Lymphoma, Mantle-Cell 9 Lymphoma, Follicular 9 Burkitt Lymphoma 9 Ovarian Neoplasms 8 Lung Neoplasms 8 Leukemia 8 Rhabdomyosarcoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Chemotherapy-induced Neutropenia 7 Breast Neoplasms, Male 6 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Febrile Neutropenia 5 Sarcoma, Ewing 4 Osteosarcoma 4 Neuroblastoma 4 Neoplasm Metastasis 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, B-Cell, Marginal Zone 4

Interventions

Trastuzumab 29 pyrotinib 15 pertuzumab 15 Docetaxel 13 Paclitaxel 7 Capecitabine 6 tucatinib 5 Carboplatin 4 neratinib 3 Ado-Trastuzumab Emtansine 3 trastuzumab deruxtecan 2 atezolizumab 2 Protons 2 Fulvestrant 2 pegfilgrastim 1 palbociclib 1 margetuximab 1 liposomal doxorubicin 1 inavolisib 1 exemestane 1 envafolimab 1 dalpiciclib 1 Taxoids 1 Neoadjuvant Therapy 1 Metformin 1 Leuprolide 1 Letrozole 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Hospital Information Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03571633 2025-11-26

BREASTIMMU02

Centre Leon Berard

Phase 2 Active not recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡